Hans-Peter Gerber insider trades

Open-market stock purchases and sales by Hans-Peter Gerber, CHIEF SCIENTIFIC OFFICER at Sutro Biopharma, Inc, from SEC Form 4 filings since Sep 18, 2023.

Recent trades

DateStockTradeValue
Sep 18, 2026STRO Sutro Biopharma, IncSold (not open market)$20.6K
Sep 18, 2026STRO Sutro Biopharma, IncBought (not open market)—
Mar 2, 2026STRO Sutro Biopharma, IncSold (not open market)$24K
Mar 2, 2026STRO Sutro Biopharma, IncBought (not open market)—
Mar 2, 2026STRO Sutro Biopharma, IncBought (not open market)—
Mar 2, 2026STRO Sutro Biopharma, IncBought (not open market)—
Mar 1, 2026STRO Sutro Biopharma, IncSold (not open market)$9.5K
Mar 1, 2026STRO Sutro Biopharma, IncBought (not open market)—
Dec 23, 2025STRO Sutro Biopharma, IncBought (not open market)—
Oct 15, 2025STRO Sutro Biopharma, IncBought$13.6K

Companies traded

  • STRO Sutro Biopharma, Inc: 1 buy, last Sep 18, 2026

Get free alerts when Hans-Peter Gerber files a new trade →